487PSURVIVAL AND QUALITY OF LIFE DATA FROM THE ACT ONE RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY OF ESPINDOLOL FOR THE TREATMENT AND PREVENTION OF CACHEXIA IN PATIENTS WITH STAGE III / IV NON-SMALL CELL LUNG CANCER OR COLORECTAL CANCER

Beadle J 1 , Coats A 2 , Ho GF 3 , Prabhash K 4 , von Haeling S 5 , Brown R 1 Show all authors , Anker S 5

Affiliations 

  • 1 Project Management, PsiOxus Therapeutics Ltd, Oxford, UK
  • 2 Monash University, Melbourne, ACT, AUSTRALIA
  • 3 Clinical Oncology, Universiti Malaya Medical, Kuala Lumpur, MALAYSIA
  • 4 Dept. Medical Oncology, Tata Memorial Hospital Centre, Mumbai, INDIA
  • 5 Department of Cardiology, Charite Medical School, Berlin, GERMANY
Ann Oncol, 2014 Sep 01;25(suppl_4):iv162-iv163.
PMID: 28172258 DOI: 10.1093/annonc/mdu331.47

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications